StonvexLoading…
StonvexStonvexStonvexCore line items from NTLA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.05M | $67.67M | $44.65M | $30.87M |
Operating Income | $-100.53M | $-440.99M | $-342.28M | $-230.80M |
Net Income | $-96.23M | $-412.69M | $-316.91M | $-101.25M |
EPS (Diluted) | $-0.81 | $-3.81 | $-2.99 | $-2.08 |
Total Assets | $758.78M | $842.13M | $925.27M | $898.89M |
Total Liabilities | $137.84M | $170.73M | $176.85M | $183.64M |
Cash & Equivalents | $134.70M | $155.46M | $193.39M | $156.17M |
Free Cash Flow OCF − CapEx | $-117.42M | $-395.87M | $-326.45M | $-249.53M |
Shares Outstanding | 120.45M | 116.32M | 115.79M | 105.33M |